Document:

Exhibit
      10.18

    

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

    

    Warrant
      No. W-July07-______

    

    Void
      after 5:00 p.m., Eastern Standard Time on July 20, 2012

    

    UNIT
      PURCHASE WARRANT

    

    DRTATTOFF,
      LLC, a California limited liability company (the “Company”),
      hereby certifies that, for value received,
      Alex
      Tringas, located at 29 Eigin Parkway, Ft. Walton Beach, FL 32548 (the
“Warrant
      Holder”)
      is the
      owner of the number of unit purchase warrants (“Warrants”)
      which
      entitles the holder thereof to purchase, at any time during the period
      commencing on the Commencement Date (as defined herein) and ending on the
      Expiration Date (as defined herein), One Thousand One Hundred Twelve (1112)
      fully paid and non-assessable units of Membership Interest (as defined in the
      Company's Operating Agreement dated as of July 5, 2005, as amended to date
      (the
      "Operating Agreement")) in the Company (each a "Unit"), each representing a
      Percentage Interest (as defined in the Operating Agreement) equal to 0.0009890%
      on a fully-diluted basis as of the date hereof at a purchase price equal to
      the
      Exercise Price (as defined below) in lawful money of the United States of
      America in cash, subject to adjustment as hereinafter provided. Each Unit shall
      include the right to receive allocations of Net Profits and Net Losses and
      distributions from the Company. For the avoidance of doubt, the securities
      which
      the Warrant Holder is permitted to purchase hereunder (whether prior to or
      after
      adjustment of the Warrant Units or securities to which this Warrant applies)
      shall be equal to 1.0998% of the total equity securities of the Company on
      a
      fully-diluted basis as of the date hereof.

     

    1. WARRANT;
      EXERCISE PRICE.

     

    1.1 This
      Warrant is issued pursuant to a Subscription Agreement dated as of the date
      hereof, by and among the Company and the Warrant Holder (the “Subscription
      Agreement”).

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    1.2 Each
      Warrant shall entitle the Warrant Holder to purchase one Unit (individually,
      a
“Warrant
      Unit”
      severally, the “Warrant
      Units”).
      Each
      Warrant Unit shall provide the holder of such Unit with a capital account
      balance equal to the exercise price paid for such Warrant Unit. 

     

    1.3 The
      purchase price payable upon exercise of each Warrant (the “Exercise
      Price”)
      shall
      be (i) in the event that the Company completes a merger of the Company with
      and
      into Lifesciences Opportunities, Inc. (the "Merger"), (A) the actual exercise
      price for a Warrant issued in the Company's next equity financing (whether
      completed before, after or contemporaneously with the Merger), subject to any
      adjustments pursuant to Section 8 to make such Warrant equivalent to the
      Warrants hereunder, (B) if no Warrant is offered in the next equity financing
      (whether completed before, after or contemporaneously with the Merger), then
      in
      such event only, the purchase price per security which the Warrant Holder is
      entitled to purchase upon the exercise of this Warrant will be equal to the
      actual purchase price paid for each such security in the next equity financing,
      or (C) if no such financing is completed by the Company after the Merger, then
      the purchase price per security which the Warrant Holder is entitled to purchase
      shall be equal to (1) the Exercise Price identified in (ii) below (as adjusted
      by the provisions of Article 8), divided by (2) the number of shares or other
      securities issuable or exchangeable for each Warrant through the Merger) or
      (ii)
      if the Warrant is exercised prior to the Merger, then the exercise price shall
      be $92.72 per Unit, subject to any adjustments pursuant to Section 8.
      Notwithstanding the foregoing, the Exercise Price and number of Warrant Units
      purchasable pursuant to each Warrant are subject to adjustment as provided
      in
      Section 8. 

     

    2. EXERCISE
      OF WARRANT; EXPIRATION DATE.
      

     

    2.1 This
      Warrant is exercisable at any time and from time to time commencing the date
      hereof (“Commencement
      Date”)
      and
      ending at 5:00 p.m., Eastern Time on June 15, 2012 (the “Expiration
      Date”),
      in
      whole or from time to time in part, at the option of the Warrant Holder, upon
      surrender of this Warrant to the Company together with a duly completed Notice
      of Exercise in the form attached hereto and payment of an amount equal to the
      then applicable Exercise Price multiplied by the number of Warrant Units then
      being purchased upon such exercise. 

     

    2.2 Each
      exercise of this Warrant shall be deemed to have been effected immediately
      prior
      to the close of business on the day on which this Warrant shall have been
      surrendered to the Company as provided in Section 2.1. At such time, the person
      or persons in whose name or names any certificates for Warrant Units shall
      be
      issuable upon such exercise as provided in Section 2.3 below shall be deemed
      to
      have become the holder or holders of record of the Warrant Units represented
      by
      such certificates.

     

    2.3 Within
      three business days after the exercise of the purchase right represented by
      this
      Warrant, the Company at its expense will use its reasonable best efforts to
      cause to be issued in the name of, and delivered to, the Warrant Holder, or,
      subject to the terms and conditions hereof, to such other individual or entity
      as such Warrant Holder (upon payment by such Warrant Holder of any applicable
      transfer taxes) may direct: 

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (a) a
      certificate or certificates for the number of full Warrant Units to which such
      Warrant Holder shall be entitled upon such exercise , and 

     

    (b) in
      case
      such exercise is in part only, a new Warrant or Warrants (dated the date hereof)
      of like tenor, stating on the face or faces thereof the number of Units
      currently stated on the face of this Warrant minus the number of such Units
      purchased by the Warrant Holder upon such exercise as provided in Section 2.2
      (in each case prior to any adjustments made thereto pursuant to the provisions
      of this Warrant).

     

    3. REGISTRATION
      AND TRANSFER ON COMPANY BOOKS.
      

     

    3.1 The
      Company (or an agent of the Company) will maintain a register containing the
      names and addresses of the Warrant Holders. Any Warrant Holder may change its,
      his or her address as shown on the warrant register by written notice to the
      Company requesting such change. 

     

    3.2 The
      Company shall register upon its books any transfer of a Warrant upon surrender
      of same as provided in Section 5. 

     

    4. RESERVATION
      OF UNITS.
      The
      Company will at all times reserve and keep available, solely for issuance and
      delivery upon the exercise of this Warrant, such Warrant Units and other stock,
      securities and property, as from time to time shall be issuable upon the
      exercise of this Warrant. As
      long
      as the Warrant shall be outstanding, the Company shall use its commercially
      reasonable efforts to cause all Warrant Units issuable upon exercise of the
      Warrants to be listed (subject to official notice of issuance) on each Exchange
      (or, if applicable on Nasdaq, NASD OTC Bulletin Board or Pink Sheets, LLC or
      any
      successor electronic quotation service and trading market) on which the
      Company's Membership Interests are then listed and/or quoted, if
      any. 

     

    5. EXCHANGE,
      TRANSFER, ASSIGNMENT OR LOSS OR MUTILATION OF WARRANTS.
      This
      Warrant is exchangeable, without expense, at the option of the Warrant Holder,
      upon presentation and surrender hereof to the Company for other warrants of
      different denominations entitling the holder thereof to purchase in the
      aggregate the same number of Units purchasable hereunder. Subject to the terms
      of Sections 6 and 7, upon surrender of this Warrant to the Company at its
      principal office or at the office of its transfer agent, if any, with the
      Assignment Form annexed hereto duly executed and funds sufficient to pay any
      transfer tax, the Company shall, without charge, execute and deliver a new
      Warrant in the name of the assignee named in such instrument of assignment
      and
      this Warrant shall be promptly canceled. Subject to the terms of Sections 6
      and
      7, this Warrant may be divided or combined with other warrants which carry
      the
      same rights upon presentation hereof at the principal office of the Company
      together with a written notice specifying the names and denominations in which
      new Warrants are to be issued and signed by the Warrant Holder hereof. The
      term
“Warrant” as used herein includes any Warrants into which this Warrant may be
      divided or exchanged. Upon receipt by the Company of reasonable evidence of
      the
      ownership of and the loss, theft, destruction or mutilation of this Warrant
      and,
      in the case of loss, theft or destruction, of indemnity reasonably satisfactory
      to the Company, or, in the case of mutilation, upon surrender and cancellation
      of the mutilated Warrant, the Company shall execute and deliver in lieu thereof
      a new Warrant of like tenor and date representing an equal number of Warrants.
      

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    6. LIMITATION
      ON EXERCISE AND SALES.
      

     

    (a)
       Each
      holder of this Warrant acknowledges that this Warrant and the Warrant Units
      have
      not been registered under the Securities Act, as of the date of issuance hereof.
      This Warrant only may be transferred in compliance with this Section 6 and
      Section 7. The Company shall be under no obligation to issue the Units covered
      by such exercise unless and until the Warrant Holder shall have executed the
      form of exercise annexed hereto that states that at the time of such exercise
      that it is then an “accredited investor” within the meaning of Rule 501 of
      Regulation D, is acquiring such Units for its own account, and will not transfer
      the Warrant Units unless pursuant to an effective and current registration
      statement under the Securities Act or an exemption from the registration
      requirements of the Securities Act and any other applicable restrictions, in
      which event the Warrant Holder shall be bound by the provisions of a legend
      or
      legends to such effect that shall be endorsed upon the certificate(s)
      representing the Warrant Units issued pursuant to such exercise. In such event,
      the Warrant Units issued upon exercise hereof shall be imprinted with a legend
      in substantially the form provided in Section 7(b). 

     

    (b) Warrant
      Holder represents and warrants that it is acquiring this Warrant for its own
      account, for purposes of investment, and not with a view to, or for sale in
      connection with, any distribution thereof within the meaning of the Securities
      Act and the rules and regulations promulgated thereunder. Warrant Holder
      represents, warrants and agrees that it will not sell, exercise, transfer or
      otherwise dispose of this Warrant (or any interest therein) or any of the Units
      purchasable upon exercise hereof, except pursuant to (i) an effective
      registration statement under the Securities Act and applicable state securities
      laws or (ii) an opinion of counsel, satisfactory to Company, that an exemption
      from registration under the Securities Act and such laws is available. Warrant
      Holder further acknowledges and agrees that Company is not required, legally
      or
      contractually, so to register or qualify the Warrant or such Units or to take
      any action to make such an exemption available. Warrant Holder understands
      that
      Company will be relying upon the truth and accuracy of the representations
      and
      warranties contained in this Section 6 in issuing this Warrant and such Units
      without first registering the issuance thereof under the Securities Act or
      qualifying or registering the issuance thereof under any state securities laws
      that may be applicable.

    

    (c) Warrant
      Holder acknowledges that (i) there is not now, and there may not be in the
      future, any public market for the Warrant, (ii) although there currently is
      not
      a public trading market for the Units, there can be no assurance that any such
      market will be created and sustained, and (iii) there can be no assurance that
      Warrant Holder will be able to liquidate its investment in Company. Warrant
      Holder represents and warrants that it is familiar with and understands the
      terms and conditions of Rule 144 promulgated under the Securities
      Act.

    

    (d)
       Warrant
      Holder represents and warrants to Company that (i) it has such knowledge and
      experience in financial and business matters as is necessary to enable it to
      evaluate the merits and risks of any investments in Company and is not utilizing
      any other person to be a purchaser representative in connection with evaluation
      of such merits and risks; and (ii) it has no need for liquidity in an investment
      in Company and is able to bear the risk of that investment for an indefinite
      period and to afford a complete loss thereof.

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    (e) Warrant
      Holder represents and warrants that it has had access to, and has been furnished
      with, all of the information it has requested from Company and has had an
      opportunity to review the books and records of Company and to discuss with
      management and members of the board of directors of Company the business and
      financial affairs of Company.

    

    (f)
       Warrant
      Holder agrees that at the time of each exercise of this Warrant, unless the
      issuance of Units issuable thereupon is pursuant to an effective registration
      statement under the Securities Act and under applicable state blue sky laws,
      Warrant Holder will provide Company with a letter embodying the representations
      and warranties set forth in subsections (b) through (e), in form and substance
      reasonably satisfactory to Company, and agrees that the certificate(s)
      representing any shares issued to it upon any exercise of this Warrant may
      bear
      such restrictive legend as Company may deem necessary to reflect the restricted
      status of such shares under the Securities Act unless Company shall have
      received from Warrant Holder an opinion of counsel to Warrant Holder, reasonably
      satisfactory in form and substance to Company and its counsel, that such
      restrictive legend is not required.

     

    7. TRANSFER
      RESTRICTIONS.

    

    (a) If,
      at the
time
      of
      the surrender of this Warrant in connection with any transfer of this Warrant,
      the transfer of this Warrant shall not be registered pursuant to an effective
      registration
      statement under the Securities Act
      and
under
      applicable state securities or blue sky laws, the Company may require, as a
      condition of allowing such transfer (i) that the Warrant Holder or transferee
      of
      this Warrant, as the case may be, furnish to the Company a written opinion
      of
      counsel (which opinion shall be in form, substance and scope customary for
      opinions of counsel in comparable transactions and reasonably satisfactory
      to
      counsel for the Company) to the effect that such transfer may be made
      without
      registration under the
      Securities Act and under applicable state securities or blue sky laws, (ii)
      that
      the holder or transferee execute and deliver to the Company an investment letter
      in form and substance acceptable to the Company, (iii) that transferee agree
      in
      writing with the Company to be bound by the terms and conditions of this Warrant
      applicable to the Warrant Holder and (iv) that the transferee be an “accredited
      investor” as defined in Regulation D promulgated under the Securities
      Act.

     

    (b) The
      Units
      issuable on the exercise of the Warrant shall bear the following
      legend:

     

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION,
      OR THE SECURITIES COMMISSION OF ANY STATE, IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    (c) The
      Holder acknowledges that the Warrant Units acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    8. ADJUSTMENT
      OF EXERCISE PRICE AND NUMBER OF UNITS DELIVERABLE.
      The
      Exercise Price and the number of Warrant Units purchasable pursuant to each
      Warrant shall be subject to adjustment from time to time as hereinafter set
      forth in this Section 8: 

     

    (a) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall issue any additional units of Membership Interest as a dividend or
      subdivide the number of outstanding Units into a greater number of units of
      Membership Interest, then in either of such cases, the then applicable Exercise
      Price per Warrant Unit purchasable pursuant to this Warrant in effect at the
      time of such action shall be proportionately reduced and the number of Warrant
      Units at that time purchasable pursuant to this Warrant shall be proportionately
      increased; and conversely, in the event the Company shall reduce the number
      of
      outstanding units of Membership Interest by combining such units into a smaller
      number of units of Membership Interest then, in such case, the then applicable
      Exercise Price per Warrant Unit purchasable pursuant to this Warrant in effect
      at the time of such action shall be proportionately increased and the number
      of
      Warrant Units at that time purchasable pursuant to this Warrant shall be
      proportionately decreased. If the Company shall, at any time during the life
      of
      this Warrant, declare a dividend payable in cash on its Membership Interest
      and
      shall at substantially the same time offer to its stockholders a right to
      purchase new units of Membership Interest from the proceeds of such dividend
      or
      for an amount substantially equal to the dividend, all units of Membership
      Interest so issued shall, for the purpose of this Warrant, be deemed to have
      been issued as a dividend. Any dividend paid or distributed upon the Membership
      Interests in units of any other class of securities convertible into units
      of
      Membership Interest shall be treated as a dividend paid in units of Membership
      Interest to the extent that units of Membership Interest are issuable upon
      conversion thereof.

     

    (b) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall be recapitalized by reclassifying its outstanding units of Membership
      Interest, (or the Company or a successor corporation shall consolidate or merge
      with or convey all or substantially all of its or of any successor corporation’s
      property and assets to any other corporation or corporations (any such other
      corporations being included within the meaning of the term “successor
      corporation” hereinbefore used in the event of any consolidation or merger of
      any such other corporation with, or the sale of all or substantially all of
      the
      property of any such other corporation to, another corporation or corporations),
      then, as a condition of such recapitalization, consolidation, merger or
      conveyance, lawful and adequate provision shall be made whereby the holder
      of
      this Warrant shall thereafter have the right to purchase, upon the basis and
      on
      the terms and conditions specified in this Warrant, in lieu of the Warrant
      Units
      theretofore purchasable upon the exercise of this Warrant, such shares of stock,
      securities or assets, as may be issued or payable with respect to, or in
      exchange for, the number of Warrant Units theretofore purchasable upon the
      exercise of this Warrant had such recapitalization, consolidation, merger,
      or
      conveyance not taken place, and the exercise price for which shall have been
      appropriately adjusted to reflect the number of securities which the Warrant
      Holder is entitled to purchase in exchange for such Warrant; and in any such
      event, the rights of the Warrant Holder to any adjustment in the number of
      Warrant Units purchasable upon the exercise of this Warrant, as herein provided,
      shall continue and be preserved in respect of any stock which the Warrant Holder
      becomes entitled to purchase.

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    (c) In
      case
      the Company at any time while this Warrant shall remain unexpired and
      unexercised shall sell all or substantially all of its property or dissolve,
      liquidate, or wind up its affairs, lawful provision shall be made as part of
      the
      terms of any such sale, dissolution, liquidation or winding up, so that the
      holder of this Warrant may thereafter receive upon exercise hereof in lieu
      of
      each Warrant Unit that it would have been entitled to receive, the same kind
      and
      amount of any securities or assets as may be issuable, distributable or payable
      upon any such sale, dissolution, liquidation or winding up with respect to
      each
      Unit of the Company, provided, however, that in any case of any such sale or
      of
      dissolution, liquidation or winding up, the right to exercise this Warrant
      shall
      terminate on a date fixed by the Company; such date so fixed to be not earlier
      than 5:00 p.m., Eastern Time, on the forty-fifth day next succeeding the date
      on
      which notice of such termination of the right to exercise this Warrant has
      been
      given by mail to the registered holder of this Warrant at its address as it
      appears on the books of the Company.

     

    9. VOLUNTARY
      ADJUSTMENT BY THE COMPANY.
      The
      Company may, at its option, at any time during the term of the Warrants, reduce
      the then current Exercise Price to any amount deemed appropriate by the Managing
      Members of the Company and/or extend the date of the expiration of the Warrants.
      

     

    10. RIGHTS
      OF THE HOLDER.
      The
      Warrant Holder shall not, by virtue hereof, be entitled to any rights of a
      member in the Company, either at law or equity, and the rights of the Warrant
      Holder are limited to those expressed in this Warrant and are not enforceable
      against the Company except to the extent set forth herein. This Warrant does
      not
      entitle the Holder to any voting rights or other rights as a member of the
      Company prior to the Exercise Date and then only with respect to the Warrant
      Units to be issued with respect thereto. 

     

    11. NOTICES
      OF RECORD DATE.
      In
      case: 

     

    (a) the
      Company shall take a record of the holders of its Units (or other stock or
      securities at the time deliverable upon the exercise of this Warrant) for the
      purpose of entitling or enabling them to receive any dividend or other
      distribution, or to receive any right to subscribe for or purchase any
      Membership Interests or any other securities, or to receive any other right,
      or

     

    (b) of
      any
      capital reorganization of the Company, any reclassification of the equity
      capital of the Company, any consolidation or merger of the Company with or
      into
      a corporation or other entity (other than a consolidation or merger in which
      the
      Company is the surviving entity), or any transfer of all or substantially all
      of
      the assets of the Company, or 

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    (c) of
      the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      

     

    then,
      and
      in each such case, the Company will mail or cause to be mailed to the Warrant
      Holder a notice specifying, as the case may be, (i) the date on which a record
      is to be taken for the purpose of such dividend, distribution or right, and
      stating the amount and character of such dividend, distribution or right, or
      (ii) the effective date on which such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up is
      to
      take place, and the time, if any is to be fixed, as of which the holders of
      record of Units (or such other stock or securities at the time deliverable
      upon
      the exercise of this Warrant) shall be entitled to exchange their Units (or
      such
      other stock or securities) for securities or other property deliverable upon
      such reorganization, reclassification, consolidation, merger, transfer,
      dissolution, liquidation or winding-up. Such notice shall be mailed at least
      ten
      days prior to the record date or effective date for the event specified in
      such
      notice, provided that the failure to mail such notice shall not affect the
      legality or validity of any such action. 

     

    12. SUCCESSORS.
      The
      rights and obligations of the parties to this Warrant will inure to the benefit
      of and be binding upon the parties hereto and their respective heirs,
      successors, assigns, pledgees, transferees and purchasers. 

     

    13. CHANGE
      OR WAIVER.
      Any
      term of this Warrant may be changed or waived only by an instrument in writing
      signed by the party against whom enforcement of the change or waiver is sought.
      

     

    14. HEADINGS.
      The
      headings in this Warrant are for purposes of reference only and shall not limit
      or otherwise affect the meaning of any provision of this Warrant. Wherever
      possible, each provision of this Warrant shall be interpreted in such manner
      as
      to be effective and valid under applicable law, but if any provision of this
      Warrant shall be prohibited by or invalid under applicable law, such provision
      shall be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provisions or the remaining provisions of
      this Warrant.

     

    15. Governing
      Law.
      This
      Warrrant shall be governed by and construed in accordance with the laws of
      the
      State of California. Any action or litigation brought by either party against
      the other concerning the transactions contemplated by this Warrant shall be
      brought only in the state courts or in the federal courts located in the state
      of California prevailing party shall be entitled to recover from the other
      party
      its reasonable attorney’s fees and costs.

     

    16. MAILING
      OF NOTICES, ETC.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the applicable
      

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    address
      set forth below, or, if sent by facsimile, upon receipt of a confirmation of
      delivery: 

    

    
      	
              Registered
                Holder:

            	
              To
                his or her last known address as indicated on the Company’s books and
                records.

            
	 	 
	
              The
                Company:

            	
              DrTattoff,
                LLC

            
	 	
              8500
                Wilshire Blvd,

            
	 	
              Beverly
                Hills CA 90211

            
	 	
              Attention:
                James Morel, President

            
	 	
              Fax:
                310-659-4159

            

    

    

    [Signature
      Page Follows]

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
      authorized officer as of July __, 2007

    

    
      	
              DRTATTOFF,
                LLC

            
	 	 
	
              By:

            	
              /s/
                James Morel

            
	
              Name:
                

            	
              James
                Morel

            
	
              Title:
                

            	
              CEO

            

    

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    Notice
      of Exercise 

    To
      Be
      Executed by the Warrant Holder

    In
      Order
      to Exercise Warrants

    

    TO:
      Dr.
      Tattoff, LLC

    

    The
      undersigned hereby: (1) irrevocably subscribes for and offers to purchase
      _______ Units (“Units”),
      of
      DrTattoff, LLC, pursuant to Warrant No. ___ heretofore issued to
      ___________________ on July 20, 2007 and (2) encloses a cash payment of
      $__________ representing the aggregate exercise price for such Unitss.

    

    The
      undersigned hereby represents and warrants to the Company that it is an
“Accredited Investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      is acquiring these securities for its own account and not with a view to, or
      for
      sale in connection with, any distribution thereof, nor with any present
      intention of distributing or selling the same. The undersigned further
      represents that it does not have any contract, agreement, understanding or
      arrangement with any person to sell, transfer or grant the Units issuable under
      this Warrant. The undersigned understands that the shares it will be receiving
      are “restricted securities” under Federal securities laws inasmuch as they are
      being acquired from DrTattoff, LLC, in transactions not including any public
      offering and that under such laws, such shares may only be sold pursuant to
      an
      effective and current registration statement under the Securities Act or an
      exemption from the registration requirements of the Securities Act and any
      other
      applicable restrictions, in which event a legend or legends will be placed
      upon
      the certificate(s) representing the Units issuable under this Warrant denoting
      such restrictions. The undersigned understands and acknowledges that the Company
      will rely on the accuracy of these representations and warranties in issuing
      the
      securities underlying the Warrant.

    

    [warrant
      notice of exercise signature page to follow]

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

        
        

      

    

     

    Exhibit
      10.18

    [warrant
      notice of exercise signature page]

    

      
        	
                Date:

              	 
	 	 
	
                Warrant
                  Holder Name:

              	 
	 	 
	
                Taxpayer Identification Number:

              	 
	 	 
	
                By:
                  

              	 
	 	 
	
                Printed
                  Name:

              	 
	 	 
	
                Title:

              	 
	 	 
	
                Address:

              	 

      

    

     

    Note:
      The
      above signature should correspond exactly with the name on the face of this
      Warrant or with the name of assignee appearing in assignment form below.

    

    AND,
      if
      said number of shares shall be less than the total number of shares purchasable
      under the Warrant, a new Warrant is to be issued in the name of said undersigned
      for the balance remaining of the shares purchasable thereunder less any fraction
      of a share paid in cash and delivered to the address stated
      above.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    ASSIGNMENT
      FORM

    To
      be
      executed by the Warrant Holder

    In
      order
      to Assign Warrants

    

    FOR
      VALUE
      RECEIVED,____________________________________ hereby sell, assigns and transfer
      unto

     

    PLEASE
      INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER

    

    
      	 

    

     

    
      

    

    
       

      
        

      

    

    
       

      
        

      

    

    (Please
      print or type name and address)

     

    ______________________
      of the Warrants represented by this Warrant, and hereby irrevocably constitutes
      and appoints ________________________ Attorney to transfer this Warrant on
      the
      books of the Company, with full power of substitution in the
      premises.

     

    
      	
              Dated:______________________

            	 
	 	
              (Signature
                of Registered Holder)

            

    

    

    In
      addition to executing this Assignment Form, the Warrant Holder and the
      transferee must comply with the other requirements for transfer set forth in
      Sections 6 and 7 of the Warrant.

     

    CERTIFICATION
      OF STATUS OF TRANSFEREE

    TO
      BE EXECUTED BY THE TRANSFEREE OF THIS WARRANT

    

    The
      undersigned transferee hereby certifies to the registered holder of this Warrant
      and to DR. TATTOFF, LLC that the transferee is an “accredited investor” within
      the meaning of Rule 501 of Regulation D promulgated under the Securities Act
      of
      1933, as amended.

    

    
      	
              Dated:_____________________

            	 
	 	
              (Signature
                of Transferee)

            

    

    
      
        
        

      

      
        13Exhibit
      10.19

    

    THIS
      SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OR EXERCISE OF HEREOF
      HAVE
      NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS SECURITY
      AND THE SECURITIES ISSUABLE UPON CONVERSION OR EXERCISE HEREOF MAY NOT BE SOLD,
      OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
      REGISTRATION STATEMENT WITH RESPECT HERETO OR THERETO UNDER SAID ACT OR AN
      OPINION OF COUNSEL REASONABLY SATISFACTORY TO DR. TATTOFF, LLC THAT SUCH
      REGISTRATION IS NOT REQUIRED.

     

    
      
        	
                Certificate
                  No. PN-[__]

              	 	
                Issue
                  Date: July 20, 2007

              
	Principal Amount
                $75,000	 	 

      

    

     

    CONVERTIBLE
      PROMISSORY NOTE

    

    FOR
      VALUE
      RECEIVED, DrTattoff, LLC, a California limited liability company, located at
      8500 Wilshire Blvd, Beverly Hills CA 90211 (hereinafter called “Borrower”),
      hereby promises to pay to Ian Kirby, located at 560 N. Kings Road #3, West
      Hollywood, CA 90048 (the “Holder”),
      without demand, the sum of Seventy Five Thousand Dollars ($75,000), plus all
      accrued and unpaid interest, on the earlier of (i) the date which is 180 days
      following Issue Date, or (ii) the date which is two (2) days after the effective
      date of the Merger (as defined below) (the “Maturity
      Date”),
      unless the Holder elects to convert this Note as set forth in Article II.

    

    ARTICLE
      I

    

    GENERAL
      PROVISIONS

    

    1.1 Interest
      Rate.
      Interest on the outstanding principal balance of this Note shall accrue,
      beginning from the date hereof, at a rate of 10% per annum, compounded
      quarterly. Interest on the outstanding principal balance of the Note shall
      be
      computed on the basis of the actual number of days elapsed and a year of three
      hundred and sixty (360) days and shall be payable on the Maturity Date, upon
      earlier prepayment of this Note or in the form of shares of New Securities
      or
      Conversion Shares (each as defined below), upon conversion of this Note as
      set
      forth in Section 1.2 below.

    

    1.2 Conversion
      Privileges.
      The
      Note shall be payable in full on the Maturity Date, unless previously converted
      into New Securities or Conversion Shares, in accordance with Article II
      hereof.

    

    1.3 Prepayment.
      This
      Note shall not be subject to any prepayment penalty in the event the Company
      determines in its sole discretion to prepay all or any portion of this
      Note.

    

    1.4 In
      no
      event shall the Borrower be obligated to pay interest and fees in excess of
      the
      amount permitted by law. Regardless of any provision herein or in any agreement
      made in connection herewith, Holder shall never be entitled to receive, charge
      or apply, as interest on any indebtedness relating hereto, any amount in excess
      of the maximum amount of interest permissible under applicable law. If Holder
      ever receives, collects or applies any such excess, it shall be deemed a partial
      repayment of principal and treated as such; and if principal is paid in full,
      any remaining excess shall be refunded to the Borrower. This paragraph shall
      control every other provision hereof and of any other agreement made in
      connection herewith.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    ARTICLE
      II

    

    CONVERSION
      RIGHTS

    

    The
      Holder shall have the right to convert the principal and any interest due under
      this Note into New Securities or Conversion Shares as set forth
      below.

    

    2.1. Borrower's
      Proposed Merger.
      The
      Borrower intends to merge itself with and into Lifesciences Opportunities,
      Inc.,
      a Delaware corporation (the "Merger"). The rights provided in this Article
      II
      shall not be exercisable unless and until completion of the Merger. For purposes
      of this Article II, the term Borrower shall refer to the surviving entity after
      completion of the Merger. 

    

    2.2 Conversion
      into the Borrower’s New Securities.

    

    (a)
      Conversion
      Right.
      Provided that the Merger is consummated, upon written notice to the Borrower,
      the Holder may, at its sole option, at the effective date of the Merger (as
      defined below), or at any time thereafter until the principal balance of this
      Note, together with all accrued and unpaid interest, is paid in full, convert
      the entire outstanding principal hereunder and all accrued and unpaid interest
      thereon into such number of shares of fully paid and non-assessable equity
      securities issued by the Borrower to its members in connection with the
      conversion of their Membership Interests in the Company pursuant to the Merger
      (the “New
      Securities”),
      that
      is equal to the quotient of (A) the outstanding principal hereunder plus
      all
      accrued and unpaid interest thereon divided
      by
      (B) the
      Conversion Price (as defined below). In addition, in connection with such
      conversion, the Holder shall receive rights as a purchaser and holder of New
      Securities (including, without limitation, customary registration rights) no
      less favorable in the aggregate and in any single instance than those granted
      to
      any other purchaser of New Securities. The Borrower agrees that it has no right
      to prevent the Holder from effecting such conversion without the Holder’s
      consent, whether by attempting to prepay this Note (whether or not there shall
      have been a default hereunder) or otherwise. The “Conversion
      Price”
shall
      (i) if the New Securities are common stock, par value $0.001 per share (the
      “Common
      Stock”),
      be
      equal to the Common Stock Equivalent Price (as defined below) or (ii) if the
      New
      Securities are convertible capital stock, the Conversion Price shall be an
      amount equal to the Common Stock Equivalent Price multiplied by the number
      of
      shares of Common Stock into which one share of such convertible capital stock
      is
      convertible. The “Common
      Stock Equivalent Price”
shall
      initially be the closing offering price in the Next Financing and shall be
      adjusted as set forth in Section 2.2(d) below. 

    

    (b)
      Fractional
      Shares.
      Upon the
      conversion of this Note, fractional shares representing New Securities shall
      be
      issued only if fractional shares are issuable in connection with the Next
      Financing to investors generally. If no fractional shares are so issuable,
      then
      with respect to any fraction of a share called for upon the conversion of this
      Note or any portion hereof, a cash amount equal to such fraction shall be paid
      to the Holder. 

    

    (c)
      Conversion
      Mechanics.
      

     

    (i)
      Notice
      of Merger.
      The
      Borrower shall notify the Holder in writing not less than 5 business days prior
      to the expected effective date of the Merger (the “Effective
      Date”).
      Such
      notice shall include all of the material terms of the Merger and shall include,
      as promptly as such documents are available, then-current drafts of the
      transaction documents for the Merger. Following such notice, the Borrower shall
      provide the Holder with any transaction documents or revised drafts thereof
      at
      the same time that such transaction documents or drafts are made generally
      available to Members of the Company in connection with the
      Merger.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (ii)
      Conversion
      Notice.
      The
      right of conversion shall be exercised by the Holder by delivering to the
      Borrower, no later than the business day prior to the date of which this Note,
      including all accrued and unpaid interest thereon, is paid in full, a conversion
      notice substantially in the form attached hereto as Exhibit
      A
      (the
“Conversion
      Notice”),
      appropriately completed and duly signed, and by surrender not later than five
      (5) business days thereafter of this Note (or if the original Note has been
      lost
      or destroyed, an affidavit of Holder in customary form certifying as to such
      loss or destruction). Promptly after the receipt of the Conversion Notice and
      the original Note (or if the original Note has been lost or destroyed, an
      affidavit of Holder in customary form certifying as to such loss or
      destruction), the Borrower shall issue and deliver, or cause to be delivered,
      to
      the Holder, a certificate or certificates for the number of shares of New
      Securities issuable to such Holder in accordance with Section 2.2(a). Such
      conversion shall be deemed to have been effected as of the date of consummation
      of surrender of the Original Note, or affidavit, as the case may be (the
“Conversion
      Date”),
      and
      the person or persons entitled to receive the shares of New Securities issuable
      upon conversion shall be treated for all purposes as the holder or holders
      of
      record of such shares as of the close of business on the Conversion
      Date.

     

    (d) 
      The
      number and kind of shares or other securities to be issued upon conversion
      determined pursuant to Section 2.2(a), shall be subject to adjustment from
      time
      to time upon the happening of certain events while this conversion right remains
      outstanding, as follows:

     

    (i) Merger,
      Sale of Assets, etc.
      If the
      Borrower at any time shall consolidate with or merge into or sell or convey
      all
      or substantially all its assets to any other corporation, this Note, as to
      the
      unpaid principal portion thereof and accrued interest thereon, shall thereafter
      be deemed to evidence the right to purchase such number and kind of shares
      or
      other securities and property as would have been issuable or distributable
      on
      account of such consolidation, merger, sale or conveyance, upon or with respect
      to the securities subject to the conversion or purchase right immediately prior
      to such consolidation, merger, sale or conveyance. The foregoing provision
      shall
      similarly apply to successive transactions of a similar nature by any such
      successor or purchaser. Without limiting the generality of the foregoing, the
      anti-dilution provisions of this Section shall apply to such securities of
      such
      successor or purchaser after any such consolidation, merger, sale or
      conveyance.

    

    (ii) Reclassification,
      etc.
      If the
      Borrower at any time shall, by reclassification or otherwise, change the Common
      Stock into the same or a different number of securities of any class or classes
      that may be issued or outstanding, this Note, as to the unpaid principal portion
      thereof and accrued interest thereon, shall thereafter be deemed to evidence
      the
      right to purchase an adjusted number of such securities and kind of securities
      as would have been issuable as the result of such change with respect to the
      Common Stock immediately prior to such reclassification or other
      change.

    

    (iii) Stock
      Splits, Combinations and Dividends.
      If the
      shares of Common Stock are subdivided or combined into a greater or smaller
      number of shares of Common Stock, or if a dividend is paid on the Common Stock
      in shares of Common Stock, the Common Stock Equivalent Price shall be
      proportionately reduced in case of subdivision of shares or stock dividend
      or
      proportionately increased in the case of combination of shares, in each such
      case by the ratio which the total number of shares of Common Stock outstanding
      immediately after such event bears to the total number of shares of Common
      Stock
      outstanding immediately prior to such event.

     

    (e) Whenever
      any action is taken pursuant to Section 2.2(d) above, the Borrower shall
      promptly mail to the Holder a notice setting forth the Conversion Price after
      such adjustment and setting forth a statement of the facts requiring such
      adjustment.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    2.3 Most
      Favored Nations Conversion Right.

    

    (a) At
      any
      time after the Effective Date until this Note, including all accrued and unpaid
      interest hereon, is paid in full, if the Borrower completes an offering of
      equity securities, then, on the date of the consummation by the Borrower of
      such
      offering of the Borrower’s equity securities (which for purposes of this Section
      2.3 includes any securities convertible into or exercisable for any of the
      Borrower’s capital stock, but does not include any Exempt Securities, as defined
      below), this Note and all accrued and unpaid interest thereon shall be
      convertible, in whole or in part and at the option of the Holder, into a number
      of shares of such equity securities equal to the quotient obtained by dividing
      (i) the principal amount of this Note being converted by the Holder (together
      with all accrued and unpaid interest thereon), by (ii) the price per security
      at
      which such equity securities are sold to other investors in such offering.
      The
      Borrower shall notify the Holder of the proposed closing date of any such
      offering no less than 3 business days, but no more than 5 business days, prior
      to such date.

    

    (b) In
      the
      event that the Holder elects to convert all or a portion of the Note pursuant
      to
      Section 2.3(a), the Holder shall surrender the Note to the Company, along with
      a
      written notice to the Company, in the manner specified in Section 2.1(c)(ii)
      hereof, at least 1 day prior to the date on which conversion is sought to become
      effective (the “MFN Conversion
      Date”)
      that
      such Holder elects to convert the Note or a specified portion thereof on the
      MFNConversion Date, and such notice shall specify the names (and addresses)
      in
      which certificates for Conversion Shares (as defined below) are to be
      issued.

    

    (c) If
      the
      Note is surrendered for conversion pursuant to Section 2.3(b), then promptly
      after the MFN Conversion Date, the Borrower shall deliver or cause to be
      delivered to the Holder certificates representing the number of fully paid
      and
      non-assessable shares of the applicable equity securities (the “Conversion
      Shares”),
      into
      which the Note may be converted. Such conversion shall be deemed to have been
      made immediately prior to the close of business on the MFN Conversion Date,
      so
      that the rights of the Holder as a holder of the Note shall cease with respect
      to the Note at such time (including, without limitation, the right to receive
      the principal amounts of the Note other than in the form of Conversion Shares),
      interest shall cease to accrue hereon and the person or persons entitled to
      receive the Conversion Shares deliverable upon conversion of the Note shall
      be
      treated for all purposes as having become the record holders of such Conversion
      Shares at such time. If this Note shall have been converted in part, the
      Borrower shall, at the time of delivery of the certificate or certificates
      representing Conversion Shares, deliver to the Holder a new Note evidencing
      the
      rights of the Holder with respect to the remaining principal amount (and all
      accrued and unpaid interest thereon), which new Note shall in all other respects
      be identical with this Note, or at the request of the Holder, appropriate
      notation may be made on this Note and the same returned to the
      Holder.

    

    (d) “Exempt
      Securities”
means
      any shares of Common Stock issued by the Borrower after the date of issuance
      of
      this Note that are: (i) shares issued or issuable upon the exercise of any
      warrants or options outstanding as of the original date of the issuance of
      this
      Note (including any warrants issued in connection with the issuance of the
      Promissory Notes); (ii) shares of Common Stock or common stock equivalents
      issued in connection with a bona-fide strategic transaction, partnership, joint
      venture or acquisition or (iii) shares of Common Stock issued in connection
      with
      any stock-based compensation plans of the Borrower, or any issuance of Common
      Stock, stock awards or options under, or the exercise of options granted
      pursuant to, any Board approved employee stock option or similar plan for the
      issuance of options or capital stock of the Borrower.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    ARTICLE
      III

    

    EVENT
      OF DEFAULT

    

    3.1 Event
      of Default.
      The
      occurrence of any of the following events of default (“Event
      of Default”)
      shall,
      at the option of the Holder hereof, make all sums of principal and interest
      then
      remaining unpaid hereon and all other amounts payable hereunder immediately
      due
      and payable, upon demand, without presentment, or grace period, all of which
      hereby are expressly waived, except as set forth below:

    

    (a) Failure
      to Pay Principal or Interest.
      The
      Borrower fails to pay principal, interest or other sum due under this Note
      when
      due and such failure continues for a period of five (5) business days after
      the
      due date. 

    

    (b) Breach
      of Covenant.
      The
      Borrower breaches any material covenant or other term or condition of the
      Subscription Agreement dated as of the date hereof by and between the Borrower
      and the Holder (the "Subscription Agreement") or this Note in any material
      respect and such breach, if capable of cure, continues for a period of thirty
      (30) days after written notice to the Borrower from the Holder.

    

    (c) Breach
      of Representations and Warranties.
      Any
      material representation or warranty of the Borrower made herein, in the
      Subscription Agreement, or in any agreement, statement or certificate given
      in
      writing pursuant hereto or in connection therewith shall be false or misleading
      in any material respect as of the date made and the Closing Date.

    

    (d) Receiver
      or Trustee.
      The
      Borrower shall make an assignment for the benefit of creditors, or apply for
      or
      consent to the appointment of a receiver or trustee for it or for a substantial
      part of its property or business; or such a receiver or trustee shall otherwise
      be appointed.

    

    (e) Judgments.
      Any
      money judgment, writ or similar final process shall be entered or filed against
      Borrower or any of its property or other assets for more than $100,000, and
      shall remain unvacated, unbonded or unstayed for a period of thirty (30)
      days.

    

    (f) Bankruptcy.
      Bankruptcy, insolvency, reorganization or liquidation proceedings or other
      proceedings or relief under any bankruptcy law or any law, or the issuance
      of
      any notice in relation to such event, for the relief of debtors shall be
      instituted by or against the Borrower and if instituted against Borrower are
      not
      dismissed within 45 days of initiation.

    

    (g) Failure
      to Deliver.
      Borrower’s failure to timely deliver New Securities or Conversion Shares to the
      Holder pursuant to and in the form required by this Note.

    

    3.2 Remedies
      Upon An Event of Default.
      If an
      Event of Default shall have occurred and shall be continuing, the Holder of
      this
      Note may at any time at its option, declare the entire unpaid principal balance
      of this Note, together with all interest accrued hereon, due and payable, and
      thereupon, the same shall be accelerated and so due and payable; provided,
      however,
      that
      upon the occurrence of an Event of Default described in Section 3.1(f), without
      presentment, demand, protest, or notice, all of which are hereby expressly
      unconditionally and irrevocably waived by the Borrower, the outstanding
      principal balance and accrued interest hereunder shall be automatically due
      and
      payable. In addition, if an Event of Default shall have occurred and be
      continuing, the
      Holder
may
      exercise or otherwise enforce any one or more of the Holder’s rights, powers,
      privileges, remedies and interests under this Note or applicable law and
institute
      such actions or proceedings in law or equity as it shall deem expedient for
      the
      protection of its rights and may prosecute and enforce its claims against all
      assets and property of the Borrower, and in connection with any such action
      or
      proceeding shall be entitled to receive from the Borrower, payment of the
      principal amount of this Note plus accrued interest to the date of payment
      plus
      reasonable expenses of collection, including, without limitation, attorneys'
      and
      experts' fees and expenses.
      No
      course of delay on the part of the Holder shall operate as a waiver thereof
      or
      otherwise prejudice the right of the Holder. No remedy conferred hereby shall
      be
      exclusive of any other remedy referred to herein or now or hereafter available
      at law, in equity, by statute or otherwise.

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    ARTICLE
      IV

    

    MISCELLANEOUS

    

    4.1 Failure
      or Indulgence Not Waiver.
      No
      failure or delay on the part of Holder hereof in the exercise of any power,
      right or privilege hereunder shall operate as a waiver thereof, nor shall any
      single or partial exercise of any such power, right or privilege preclude other
      or further exercise thereof or of any other right, power or privilege. All
      rights and remedies existing hereunder are cumulative to, and not exclusive
      of,
      any rights or remedies otherwise available.

    

    4.2 Notices.
      All
      notices, demands, requests, consents, approvals, and other communications
      required or permitted hereunder shall be in writing and, unless otherwise
      specified herein, shall be (i) personally served, (ii) deposited in the mail,
      registered or certified, return receipt requested, postage prepaid, (iii)
      delivered by reputable air courier service with charges prepaid, or (iv)
      transmitted by hand delivery, telegram, or facsimile, addressed as set forth
      below or to such other address as such party shall have specified most recently
      by written notice. Any notice or other communication required or permitted
      to be
      given hereunder shall be deemed effective (a) upon hand delivery or delivery
      by
      facsimile, with accurate confirmation generated by the transmitting facsimile
      machine, at the address or number designated below (if delivered on a business
      day during normal business hours where such notice is to be received), or the
      first business day following such delivery (if delivered other than on a
      business day during normal business hours where such notice is to be received)
      or (b) on the second business day following the date of mailing by express
      courier service, fully prepaid, addressed to such address, or upon actual
      receipt of such mailing, whichever shall first occur. The addresses for such
      communications shall be the addresses set forth in the Subscription
      Agreement.

    

    4.3 Assignability.
      This
      Note shall be binding upon the Borrower and its successors and assigns, and
      shall inure to the benefit of the Holder and its successors and assigns. This
      Note may not be assigned by the Holder without the prior written consent of
      the
      Company, except to an Affiliate of Holder that is an “accredited investor” as
      such term is defined in Regulation D under the 1933 Act.

    

    4.4 Cost
      of Collection.
      If
      default is made in the payment of this Note, Borrower shall pay the Holder
      hereof its reasonable costs of collection, including reasonable attorneys’
fees.

    

    4.5 Remedies,
      Characterizations, Other Obligations, Breaches and Injunctive
      Relief.
      The
      remedies provided in this Note shall be cumulative and in addition to all other
      remedies available under this Note, at law or in equity (including, without
      limitation, a decree of specific performance and/or other injunctive relief),
      no
      remedy contained herein shall be deemed a waiver of compliance with the
      provisions giving rise to such remedy and nothing herein shall limit a Holder’s
      right to pursue actual damages for any failure by the Borrower to comply with
      the terms of this Note. Amounts set forth or provided for herein with respect
      to
      payments and the like (and the computation thereof) shall be the amounts to
      be
      received by the Holder. The Borrower acknowledges that a breach by it of its
      obligations hereunder will cause irreparable and material harm to the Holder
      and
      that the remedy at law for any such breach may be inadequate. Therefore the
      Borrower agrees that, in the event of any such breach or threatened breach,
      the
      Holder shall be entitled, in addition to all other available rights and
      remedies, at law or in equity, to such equitable relief, including but not
      limited to an injunction restraining any such breach or threatened breach,
      without the necessity of showing economic loss and without any bond or other
      security being required.

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    4.6 Payment
      Not Subject to Set-Off.
      The
      Borrower acknowledges that it has no and will not be permitted to assert any
      right of set-off or counterclaim with respect to its obligation to pay the
      principal and interest as of the Maturity Date as set forth herein and hereby
      waives any and all defenses it may have in the future with respect to such
      payment, except to the extent that (a) this Note is converted in accordance
      with
      Article II prior to the Maturity Date, (b) Borrower’s defense is that Borrower
      has paid all principal and interest hereon in accordance with the terms hereof
      or (c) the Holder has expressly waived its right to such payment in a writing
      signed by Holder.

    

    4.7 Governing
      Law.
      This
      Note shall be governed by and construed in accordance with the laws of the
      State
      of California. Any action brought by either party against the other concerning
      the transactions contemplated by this Note shall be brought only in the state
      or
      federal courts of located in the state of California. The prevailing party
      shall
      be entitled to recover from the other party its reasonable attorney’s fees and
      costs.

    

    4.8 Shareholder
      Status.
      The
      Holder shall not have rights as a shareholder of the Borrower with respect
      to
      unconverted portions of this Note. However, the Holder will have all the rights
      of a shareholder of the Borrower with respect to the New Securities and/or
      Conversion Shares to be received by Holder after delivery by the Holder of
      a
      Conversion Notice and
      effectiveness of conversion in accordance with this Note.

    

    4.9 Waiver
      of Presentment.
      The
      Borrower expressly waives presentment, protest, demand, notice of dishonor,
      presentment for the purpose of accelerating maturity, and diligence in
      collection. 

    

    [Signature
      page follows.]

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF,
      Borrower has caused this Note to be signed in its name by an authorized officer
      as of the 24th day of July, 2007.

    

    
      	
              DRTATTOFF,
                LLC

            
	 	 
	
              By:

            	
              /s/
                James Morel

            
	
              Name:

            	
              James
                Morel

            
	
              Title:

            	
              CEO

            

    

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    EXHIBIT
      A

    

    FORM
      OF
      CONVERSION NOTICE

    

    (To
      be
      executed by the Holder in order to convert the Note.)

    

    The
      undersigned hereby irrevocably elects to convert the Convertible Promissory
      Note
      (the “Note”) of DrTattoff, LLC, a California limited liability company (the
“Company”),
      held
      by the undersigned into shares of [New Securities in connection with the Next
      Financing][Conversion Shares], according to the terms and conditions of the
      Note
      and the conditions hereof. The undersigned hereby requests that certificates
      for
      the shares of New Securities or Conversion Shares to be issued to the
      undersigned pursuant to this Conversion Notice be issued in the name of, and
      delivered to, the undersigned as indicated below. A copy of the Note being
      converted is attached hereto (and the original Note shall be transmitted to
      the
      Corporation pursuant to the terms thereof). All capitalized terms used in this
      Conversion Notice, but not otherwise defined herein shall have the meanings
      assigned in the Note. Execution and delivery of this Conversion Notice by
      facsimile shall be valid an binding for all purposes and shall be effective
      upon
      such facsimile transmission.

    

    
      	 	
              Date
                of Notice

            
	 	 
	 	 
	 	
              Conversion
                Information:[NAME OF HOLDER]

            
	 	 
	 	 
	 	
              Address
                of Holder:

            
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	
              Name
                of Holder

            

    

    

    

    
      	 	
              By:

            	 
	 	
              Name:

            	 
	 	
              Title:

            	 

    

    

    Note:
      Subject to the terms and conditions of the Note, conversion shall be effected
      upon consummation of the applicable financing and the New Securities or
      Conversion Shares shall be delivered to Holder only after receipt by the Company
      of the original Note or an affidavit of loss in customary
      form.

    
      
         

      

      
        9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]